All the latest news and information on the cannabis and psychedelics industries, with updates from the UK and across the globe.
Moving into October, cannabis reform has been on the agenda of a number of countries across Europe. Now that campaigners and advocates are finally gaining recognition for their efforts, let’s…
It appears that Belgium could become the next European country to legalise cannabis after the Deputy Prime Minister and Minister of the Economy and Employment, Pierre-Yves Dermagne, recently declared that…
Much of the research focus on psychedelics revolves around their potential application to treatment-resistant mental health conditions such as depression and PTSD. However, could these mind opening drugs have applications…
Amidst the evolving landscape of drug policy in the UK, an important debate is emerging. An upcoming report from First Wednesdays, Europe’s largest community of entrepreneurs and investors in the…
Cancard launched in November 2020, aiming to provide patients with legal support in the event of a police stop and search, when in possession of their medication. In the 3…
The US Department of Health and Human Services (HHS) has officially recommended that cannabis should be rescheduled under federal law, with the possibility of becoming one of the most significant…
Thailand legalised cannabis in June 2022, removing it from the national narcotics list. Let’s explore the state of play a year later. How did Thailand legalise cannabis? In June 2022,…
Over the last few months, there’s been a push from the government to ‘crack down’ on antisocial behaviour and stamp out illegal drugs in communities. Why are the conservatives cracking…
The days of the Silk Road and Dread Pirate Roberts may be behind us, but darknet drug markets appear to be as prevalent as ever. With the collapse of the…
A new report has revealed that approximately 29.6 million people (50.2%) in the UK could be entitled to a medicinal cannabis prescription, yet just 0.048% of the population has been…
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept